AIM ImmunoTech (AIM) EBITDA Margin Growth (3y) (2013 - 2026)
AIM ImmunoTech (AIM) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.89 Bn | 131.04 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 86.05 Bn | 78.06 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 65.56 Bn | 60.38 Bn | 1.37 Bn | -537.00 |
| 4 | Moderna | 55.46 Bn | 50.32 Bn | 52.00 Mn | -1,934.00 |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 7,261.00 |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 9,003.00 |
| 7 | BioNTech SE | 27.70 Bn | 9.30 Bn | 668.28 Mn | -11,254.00 |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 30,461.00 |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | -2,649.00 |
| 10 | AIM ImmunoTech | 4.46 Mn | -5.51 Mn | 21,000.00 | -50,916.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -50,916.00 |
| Mar 31, 2026 | -135,288.00 |
| Dec 31, 2025 | -413,571.00 |
| Sep 30, 2025 | 2.16 Mn |
| Jun 30, 2025 | 506,600.00 |
| Mar 31, 2025 | -1.31 Mn |
| Dec 31, 2024 | 187,889.00 |
| Sep 30, 2024 | -91,965.00 |
| Jun 30, 2024 | 877,722.00 |
| Mar 31, 2024 | -96,000.00 |
| Dec 31, 2023 | -928,271.00 |
| Sep 30, 2023 | -841,316.00 |
| Jun 30, 2023 | -465,238.00 |
| Mar 31, 2023 | -137,642.00 |
| Dec 31, 2022 | -374,543.00 |
| Sep 30, 2022 | -2.58 Mn |
| Jun 30, 2022 | -453,276.00 |
| Dec 31, 2021 | -1.38 Mn |
| Sep 30, 2021 | -391,132.00 |
| Jun 30, 2021 | -638,643.00 |